List of Studies ( Metabolite:PC P-40:6 or PC O-40:7)
| Study_id | Analysis_id | Study_title | Source | Species | Disease | Institute | Analysis Type |
|---|---|---|---|---|---|---|---|
| ST004333 | AN007236 | Oxidative pentose phosphate pathway is required for T cell activation and anti-tumor immunity - G6PD-knockout | T-cells | Mouse | Cancer | Princeton University | LC-MS |
| ST004132 | AN006847 | Metabolite profiling of portal plasma, cardiac puncture plasma, and cecal contents of 129 T, 129 J, C57Bl6 mice. | Blood | Mouse | Diabetes | Broad Institute of MIT and Harvard | LC-MS |
| ST004132 | AN006847 | Metabolite profiling of portal plasma, cardiac puncture plasma, and cecal contents of 129 T, 129 J, C57Bl6 mice. | Cecal content | Mouse | Diabetes | Broad Institute of MIT and Harvard | LC-MS |
| ST004093 | AN006784 | Autoimmune Disease Risk Gene ANKRD55 Promotes T Cell Proliferation and Th17 2 Effector Function Through Metabolic Modulation | T-cells | Mouse | Autoimmune disease | Broad Institute of MIT and Harvard | LC-MS |
| ST003805 | AN006255 | Epigenetic changes, neuronal dysregulation and behavioral abnormalities in Zmym2+/- mutant mice, a genetic animal model of schizophrenia and neurodevelopmental disorders | Brain | Mouse | Neurodevelopment Disorder | Broad Institute of MIT and Harvard | LC-MS |
| ST003805 | AN006255 | Epigenetic changes, neuronal dysregulation and behavioral abnormalities in Zmym2+/- mutant mice, a genetic animal model of schizophrenia and neurodevelopmental disorders | Brain | Mouse | Schizophrenia | Broad Institute of MIT and Harvard | LC-MS |
| ST003788 | AN006444 | Pre-treatment untargeted cerebrospinal fluid metabolomic profiling in tuberculous meningitis reveals multiple pathways associated with mortality | Cerebrospinal fluid | Human | Meningitis | Broad Institute of MIT and Harvard | LC-MS |
| ST003788 | AN006444 | Pre-treatment untargeted cerebrospinal fluid metabolomic profiling in tuberculous meningitis reveals multiple pathways associated with mortality | Cerebrospinal fluid | Human | Tuberculosis | Broad Institute of MIT and Harvard | LC-MS |
| ST003514 | AN005769 | Highly reliable LC-MS lipidomics database for efficient human plasma profiling based on NIST SRM 1950 | Blood | Human | Universidad CEU San Pablo | LC-MS | |
| ST003293 | AN005392 | High Fat Feeding Alters Circulating Triglyceride Profile by Decreasing SCD Activity and Depleting omega-3 Fatty Acids | Blood | Rat | Hyperlipidemia | University of Southern California | LC-MS |
| ST003266 | AN005350 | Metabolomics analysis of human spermatozoa reveals impaired metabolic pathways in asthenozoospermia | Spermatozoa | Human | University of Aveiro | LC-MS | |
| ST003266 | AN005351 | Metabolomics analysis of human spermatozoa reveals impaired metabolic pathways in asthenozoospermia | Spermatozoa | Human | University of Aveiro | LC-MS | |
| ST003103 | AN005077 | Reinforcing the Evidence of Mitochondrial Dysfunction in Long COVID Patients using a Multiplatform Mass Spectrometry-based Metabolomics Approach | Blood | Human | COVID-19 | Universidad CEU San Pablo | GC-MS/LC-MS |
| ST002817 | AN004584 | Investigation of metabolism in hypertrophic cardiomyopathy - Lipidomics | Heart | Mouse | Cardiomyopathy | University of California, San Francisco | LC-MS |
| ST002764 | AN004499 | Identification of pre-diagnostic lipid sets associated with liver cancer risk using untargeted lipidomics and chemical set analysis – a nested case-control study within the ATBC cohort | Blood | Human | Cancer | Icahn School of Medicine at Mount Sinai | LC-MS |
| ST002700 | AN004376 | Metabolomic analysis of maternal mid-gestation plasma and cord blood: lipidomics | Blood | Human | Autism | Columbia University | LC-MS |
| ST002545 | AN004192 | Lipidomic profile of Toxoplasma gondii-infected mice (Positive mode MS) | Blood | Mouse | Cachexia | University of Virginia | LC-MS |
| ST002002 | AN003265 | A case-control study on plasma metabolomics analysis in Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) (Part 3) | Blood | Human | Myalgic encephalomyelitis/chronic fatigue syndrome | Columbia University | LC-MS |
| ST001942 | AN003185 | Lipidomics of esophageal adenocarcinoma | Esophagus | Human | Cancer | QIMR Berghofer Medical Research Institute | LC-MS |
| ST001888 | AN003059 | A Metabolome Atlas of the Aging Mouse Brain (Study part II) | Brain | Mouse | University of California, Davis | GC-MS/LC-MS | |
| ST001843 | AN002986 | Identification of unique metabolite networks between Latino and Caucasian patients with nonalcoholic fatty liver disease (NAFLD) (part II) | Blood | Human | Fatty liver disease | University of California, Davis | GC-MS |
| ST001843 | AN002986 | Identification of unique metabolite networks between Latino and Caucasian patients with nonalcoholic fatty liver disease (NAFLD) (part II) | Liver | Human | Fatty liver disease | University of California, Davis | GC-MS |
| ST001815 | AN002946 | Metabolic Markers of Methotrexate Response in Juvenile Idiopathic Arthritis | Blood | Human | Arthritis | University of Kansas | GC-MS/LC-MS |
| ST001637 | AN002677 | A Metabolome Atlas of the Aging Mouse Brain | Brain | Mouse | University of California, Davis | GC-MS/LC-MS | |
| ST001521 | AN002534 | Plasma metabolites of known identity profiled using hybrid nontargeted methods (part-III) | Blood | Human | Broad Institute of MIT and Harvard | LC-MS | |
| ST001246 | AN002070 | TFPa/HADHA is required for fatty acid beta-oxidation and cardiolipin re-modeling in human cardiomyocytes (part-I) | Cultured cells | Human | Sudden infant death syndrome | University of California, Davis | LC-MS |
| ST001211 | AN002018 | Metabolomic Markers of Methotrexate Response, In Vitro | Cultured cells | Human | University of Kansas | GC-MS/LC-MS | |
| ST001151 | AN001899 | 4-day dietary effect of fast food vs Mediterranean diet to HDL lipidome | Blood | Human | University of California, Davis | LC-MS | |
| ST001102 | AN001791 | Physiological and metabolic response of crab megalopae and juveniles to ocean acidification (part-II) | Whole animals | Dungeness crab | NOAA NWFSC | LC-MS | |
| ST001067 | AN001746 | Lipidomics analysis for aged mice femoral muscle (part - IV) | Adipose tissue | Mouse | Takeda Pharmaceutical Company Limited | LC-MS | |
| ST001067 | AN001746 | Lipidomics analysis for aged mice femoral muscle (part - IV) | Brain | Mouse | Takeda Pharmaceutical Company Limited | LC-MS | |
| ST001067 | AN001746 | Lipidomics analysis for aged mice femoral muscle (part - IV) | Liver | Mouse | Takeda Pharmaceutical Company Limited | LC-MS | |
| ST001067 | AN001746 | Lipidomics analysis for aged mice femoral muscle (part - IV) | Muscle | Mouse | Takeda Pharmaceutical Company Limited | LC-MS | |
| ST001066 | AN001744 | Lipidomics analysis for aged mice liver (part-III) | Adipose tissue | Mouse | Takeda Pharmaceutical Company Limited | LC-MS | |
| ST001066 | AN001744 | Lipidomics analysis for aged mice liver (part-III) | Brain | Mouse | Takeda Pharmaceutical Company Limited | LC-MS | |
| ST001066 | AN001744 | Lipidomics analysis for aged mice liver (part-III) | Liver | Mouse | Takeda Pharmaceutical Company Limited | LC-MS | |
| ST001066 | AN001744 | Lipidomics analysis for aged mice liver (part-III) | Muscle | Mouse | Takeda Pharmaceutical Company Limited | LC-MS | |
| ST001063 | AN001739 | Lipidomics analysis for aged mice organs | Adipose tissue | Mouse | Takeda Pharmaceutical Company Limited | LC-MS | |
| ST001063 | AN001739 | Lipidomics analysis for aged mice organs | Brain | Mouse | Takeda Pharmaceutical Company Limited | LC-MS | |
| ST001063 | AN001739 | Lipidomics analysis for aged mice organs | Liver | Mouse | Takeda Pharmaceutical Company Limited | LC-MS | |
| ST001063 | AN001739 | Lipidomics analysis for aged mice organs | Muscle | Mouse | Takeda Pharmaceutical Company Limited | LC-MS | |
| ST000991 | AN001617 | Validating Quantitative Untargeted Lipidomics Across Nine Liquid Chromatography−High-Resolution Mass Spectrometry Platforms (part IX) | Blood | Human | University of California, Davis | LC-MS | |
| ST000990 | AN001616 | Validating Quantitative Untargeted Lipidomics Across Nine Liquid Chromatography−High-Resolution Mass Spectrometry Platforms (part VIII) | Blood | Human | University of California, Davis | LC-MS | |
| ST000989 | AN001615 | Validating Quantitative Untargeted Lipidomics Across Nine Liquid Chromatography−High-Resolution Mass Spectrometry Platforms (part VII) | Blood | Human | University of California, Davis | LC-MS | |
| ST000988 | AN001614 | Validating Quantitative Untargeted Lipidomics Across Nine Liquid Chromatography−High-Resolution Mass Spectrometry Platforms (part VI) | Blood | Human | University of California, Davis | LC-MS | |
| ST000987 | AN001613 | Validating Quantitative Untargeted Lipidomics Across Nine Liquid Chromatography−High-Resolution Mass Spectrometry Platforms (part V) | Blood | Human | University of California, Davis | LC-MS | |
| ST000986 | AN001612 | Validating Quantitative Untargeted Lipidomics Across Nine Liquid Chromatography−High-Resolution Mass Spectrometry Platforms (part IV) | Blood | Human | University of California, Davis | LC-MS | |
| ST000985 | AN001611 | Validating Quantitative Untargeted Lipidomics Across Nine Liquid Chromatography−High-Resolution Mass Spectrometry Platforms (part III) | Blood | Human | University of California, Davis | LC-MS | |
| ST000984 | AN001610 | Validating Quantitative Untargeted Lipidomics Across Nine Liquid Chromatography−High-Resolution Mass Spectrometry Platforms (part II) | Blood | Human | University of California, Davis | LC-MS | |
| ST000983 | AN001609 | Validating Quantitative Untargeted Lipidomics Across Nine Liquid Chromatography−High-Resolution Mass Spectrometry Platforms (Part I) | Blood | Human | University of California, Davis | LC-MS | |
| ST000879 | AN001432 | Diet, genetics and gut microbiome drive dynamic changes in plasma metabolites [plasma] | Blood | Mouse | Broad Institute of MIT and Harvard | LC-MS | |
| ST000423 | AN000671 | Differences in mycoplasma growth due to different mediums | Cells | Mouse | University of California, Davis | LC-MS | |
| ST000354 | AN000577 | Metabolite comparison of mouse gastric tissue and glands | Stomach | Mouse | University of California, Davis | LC-MS | |
| ST000346 | AN000561 | Metabolites detected from human bronchoalveolar lavage | Lung | Human | University of California, Davis | LC-MS | |
| ST000339 | AN000550 | Metabolites in peritoneal macrophages and bone marrow derived macrophages | Cells | Mouse | University of California, Davis | LC-MS | |
| ST000331 | AN000529 | Effects of Zinc on GI tract metabolites (Part 2: Prostate) | Prostate | Mouse | University of California, Davis | LC-MS | |
| ST000330 | AN000527 | Effects of Zinc on GI tract metabolites | Esophagus | Mouse | University of California, Davis | LC-MS | |
| ST000329 | AN000525 | Minimal change disease and focal segmental sclerosis in urine | Urine | Human | Kidney disease | University of California, Davis | LC-MS |
| ST000328 | AN000523 | Primary metabolites at different points along dog gastrointestinal tract (CSH chromatography) | Colon | Dog | University of California, Davis | LC-MS | |
| ST000328 | AN000523 | Primary metabolites at different points along dog gastrointestinal tract (CSH chromatography) | Duodenum | Dog | University of California, Davis | LC-MS | |
| ST000328 | AN000523 | Primary metabolites at different points along dog gastrointestinal tract (CSH chromatography) | Ileum | Dog | University of California, Davis | LC-MS | |
| ST000328 | AN000523 | Primary metabolites at different points along dog gastrointestinal tract (CSH chromatography) | Rectum | Dog | University of California, Davis | LC-MS | |
| ST000324 | AN000516 | Progesterone level effects on primary metabolites in uterus, blood, and ovaries (Part 3:Ovaries) | Follicular fluid | Cow | University of California, Davis | LC-MS | |
| ST000322 | AN000512 | Progesterone level effects on primary metabolites in uterus, blood, and ovaries (Part 1:Plasma) | Blood | Cow | University of California, Davis | LC-MS | |
| ST000321 | AN000510 | Effects of LGG on current drinkers gut metabolism | Feces | Mouse | Alcoholism | University of California, Davis | LC-MS |
| ST000317 | AN000503 | Role of medium in bacterial growth | Bacterial cells | Bacteria | University of California, Davis | LC-MS | |
| ST000089 | AN000141 | A study of changes in lipid metabolism of ovarian cancer cells co-cultured with adipocytes: UHPLC-QTOF MS analysis | Ovarian cancer cells | Human | Cancer | University of California, Davis | LC-MS |
| ST000089 | AN000142 | A study of changes in lipid metabolism of ovarian cancer cells co-cultured with adipocytes: UHPLC-QTOF MS analysis | Ovarian cancer cells | Human | Cancer | University of California, Davis | LC-MS |
| ST000082 | AN000133 | Metabolic Profiling of Visceral and Subcutaneous Adipose Tissue from Colorectal Cancer Patients: UHPLC-QTOF MS analyis of serum samples | Blood | Human | Cancer | University of California, Davis | LC-MS |
| ST000077 | AN000123 | Metabolite changes associated with methionine stress sensitivity of cancer (CSH QTOF MS analysis) | Breast cancer cells | Human | Cancer | University of California, Davis | LC-MS |
| ST000075 | AN000119 | Combined Metabolomics and Lipidomics of Type 1 Diabetes (QTOF) | Blood | Mouse | Diabetes | University of California, Davis | LC-MS |
